Atlas Trials

Safety and Efficacy Study of XELOX vs. Oxaliplatin+5-FU CI as First Line Treatment in Metastatic Colorectal Cancer

Clinical trial NCT00202774 · COMPLETED

Trial details

NCT number
NCT00202774
Sponsor
Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Colorectal Cancer
Start date
2002-04-01
Primary completion
2004-08-01
Enrollment
348

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.